Home News

On 27 and 28 November, the RegenBell Symposium on Stem Cells and Regenerative Medicine, organised by IDIBELL, has brought together national and European researchers to share and discuss the latest advances in this cutting-edge science field.
With its third edition, this conference reaffirms its main objective: to establish a platform for discussion and idea exchange between professionals of all levels interested in the subject.
Throughout the day on Thursday and Today’s morning, more than 170 people have attended the 11 expert conferences, 38 posters and 8 short talks.

According to the results published in Nature Aging, treating blood stem cells ex vivo with the molecule Rhosin leads to their rejuvenation and helps produce healthier blood cells.
Previously, IDIBELL, P-CRM[C] and ICREA Research Professor Dr M. Carolina Florian proved the central role of blood stem cells in the aging of the whole body, suggesting blood rejuvenation as an important biomedical strategy to extend healthspan and lifespan.
Biomedical strategies that ameliorate the detrimental health effects of ageing will be essential in the future scenario: by 2050, the number of people over 60 years of age will have doubled.

A research team at P-CRM[C] and IDIBELL reveals the genetic events that cause blood stem cell depletion and how these accelerate leukaemia development in patients with GATA2
The study was conducted using advanced models of this genetic disorder generated by the researchers.

We are pleased to announce the RegenBell 2025 symposium on Stem Cells and Regenerative Medicine, which will take place on November 27-28th at the Institut d’Estudis Catalans (IEC), downtown in Barcelona. The primary goal is to establish an inclusive and collaborative platform for scientists interested in Regenerative Medicine.

For the first time, a RegenBell research team has generated via 3D bioprinting a patch of heart tissue that survives and beats correctly for at least one month after implantation.
Thanks to technological advances, basic research with a clinical orientation and collaboration among groups, RegenBell opens up new therapeutic avenues for cardiovascular diseases.

The results obtained in an IDIBELL study open the door to therapies based on these cells to treat the adverse effects of radiation and improve inflammatory bowel disease.

The aim of the conference was to promote interaction between the two areas in order to generate new synergies and nurture existing ones between the researchers at the Bellvitge Campus.
The event was structured around three roundtables and closed with a joint discussion in which new horizons and challenges of research in translational and regenerative medicine were explored.

After the good reception of the first edition in 2023, the second edition of the RegenBell Symposium was held this year on November 21 and 22.
The main objective of this conference is to establish a platform for discussion and ideaexchange between professionals in the subject.
Throughout all Thursday and Friday morning, 11 conferences were presented, 9 of them by guest speakers, 8 selected short talks, and 39 posters, all around stem cells and regenerative medicine.

Jordi Guiu and Gabriel Capellá will carry out their research projects in sexual and reproductive health thanks to the funds raised by La Marató 2023.

Researchers from IDIBELL and the UB identify 15 new cell populations in the pancreas.
Led by Dr. Meritxell Rovira thanks to the CRIS Program of Excellence 2023, this new study will provide a better understanding of how pancreatic cancer develops.